Cargando…
Can selective serotonin reuptake inhibitors have a neuroprotective effect during COVID-19?
The absence of a specific treatment for SARS-CoV-2 infection led to an intense global effort in order to find new therapeutic interventions and improve patient outcomes. One important feature of COVID-19 pathophysiology is the activation of immune cells, with consequent massive production and releas...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832208/ https://www.ncbi.nlm.nih.gov/pubmed/33022271 http://dx.doi.org/10.1016/j.ejphar.2020.173629 |